KatherineTuckerMD

PubMed

• Radical hysterectomy case volume and cervical cancer treatment in the era of COVID-19: A multi-site analysis of National Cancer Institute-designated Comprehensive Canc...
  Natalie E Wickenheisser, Mairead Dillon, Gloria Broadwater, Kathleen Zacherl, Kristin Bixel, Monica Levine, Meredith Newton, Hannah Thel, Katherine Tucker, Paola Gehri...> ;Gynecologic Oncology. 2023 Dec 1
• Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in Ovarian Cancer Cells and a Transgenic Mouse Model of Ovarian Cancer.
  Yu Huang, Yali Fan, Ziyi Zhao, Xin Zhang, Katherine Tucker, Allison Staley, Hongyan Suo, Wenchuan Sun, Xiaochang Shen, Boer Deng, Stuart R Pierce, Lindsay West, Yajie ...> ;International Journal of Molecular Sciences. 2023 Aug 3
• 1 citations
  A prospective randomized trial of standard versus multimedia-supplemented counseling in patients undergoing endometrial cancer staging surgery.
  Katherine Tucker, Stephanie Sullivan, Allison M Deal, Kathryn Allman, Luz Cuaboy, Sean D McCabe, Paola A Gehrig> ;Gynecologic Oncology. 2022 Sep 1
• 9 citations
  Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian Cancer.
  Yali Fan, Jiandong Wang, Ziwei Fang, Stuart R Pierce, Lindsay West, Allison Staley, Katherine Tucker, Yajie Yin, Wenchuan Sun, Weimin Kong, Varun Prabhu, Joshua E Alle...> ;Frontiers in Oncology. 2022 Jan 1
• 1 citations
  ONC206 has anti-tumorigenic effects in human ovarian cancer cells and in a transgenic mouse model of high-grade serous ovarian cancer.
  Katherine Tucker, Yajie Yin, Stuart-Allison Staley, Ziyi Zhao, Ziwei Fang, Yali Fan, Xin Zhang, Hongyan Suo, Wenchuan Sun, Varun Vijay Prabhu, Joshua E Allen, Chunxiao...> ;American Journal of Cancer Research. 2022 Jan 1
• 1 citations
  Accuracy of preoperative cross-sectional imaging in cervical cancer patients undergoing primary radical surgery.
  S. Allison Staley, Katherine R. Tucker, Paola A. Gehrig, Leslie H. Clark> ;Gynecologic Oncology. 2021 Feb 1
• Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer.
  Allison Staley, Katherine Tucker, Yajie Yin, Xin Zhang, Yali Fan, Yingao Zhang, Ziwei Fang, Wenchuan Sun, Hongyan Suo, Xiaoling Zhao, Ziyi Zhao, Varun Vijay Prabhu, Jo...> ;American Journal of Cancer Research. 2021 Jan 1
• Join now to see all